Ted W Love - Net Worth and Insider Trading
Ted W Love Net Worth
The estimated net worth of Ted W Love is at least $71 Million dollars as of 2024-04-27. Ted W Love is the See Remarks of Global Blood Therapeutics Inc and owns about 1,037,133 shares of Global Blood Therapeutics Inc (GBT) stock worth over $71 Million. Ted W Love is also the Director of Cascadian Therapeutics Inc and owns about 27,209 shares of Cascadian Therapeutics Inc (CASC) stock worth over $272,634. Details can be seen in Ted W Love's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ted W Love has not made any transactions after 2020-04-28 and currently still holds the listed stock(s).
Transaction Summary of Ted W Love
Ted W Love Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ted W Love owns 12 companies in total, including Seagen Inc (SGEN) , Royalty Pharma PLC (RPRX) , and Global Blood Therapeutics Inc (GBT) among others .
Click here to see the complete history of Ted W Love’s form 4 insider trades.
Insider Ownership Summary of Ted W Love
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SGEN | Seagen Inc | 2022-05-13 | director |
| RPRX | Royalty Pharma PLC | 2022-06-24 | director |
| GBT | Global Blood Therapeutics Inc | 2020-04-28 | director & See Remarks |
| PTLA | Portola Pharmaceuticals Inc | 2020-07-02 | director |
| FOLD | Amicus Therapeutics Inc | 2012-06-13 | director |
| CASC | Cascadian Therapeutics Inc | 2018-03-09 | director |
| HGENQ | Humanigen Inc | 2012-08-10 | director |
| SVRA | Savara Inc | 2012-09-05 | director |
| AFFY | Affymax Inc | 2012-06-13 | director |
| BIO | Bio-Rad Laboratories Inc | 2010-03-24 | director |
| ABIO | ARCA biopharma Inc | 2004-05-07 | President and C.E.O. |
| GPCR | Structure Therapeutics Inc | 2023-08-03 | director |
Ted W Love Latest Holdings Summary
Ted W Love currently owns a total of 2 stocks. Among these stocks, Ted W Love owns 1,037,133 shares of Global Blood Therapeutics Inc (GBT) as of April 28, 2020, with a value of $71 Million and a weighting of 99.62%. Ted W Love also owns 27,209 shares of Cascadian Therapeutics Inc (CASC) as of February 2, 2017, with a value of $272,634 and a weighting of 0.38%.
Latest Holdings of Ted W Love
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GBT | Global Blood Therapeutics Inc | 2020-04-28 | 1,037,133 | 68.49 | 71,033,239 |
| CASC | Cascadian Therapeutics Inc | 2017-02-02 | 27,209 | 10.02 | 272,634 |
Holding Weightings of Ted W Love
Ted W Love Form 4 Trading Tracker
According to the SEC Form 4 filings, Ted W Love has made a total of 4 transactions in Global Blood Therapeutics Inc (GBT) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Global Blood Therapeutics Inc is the sale of 42,817 shares on April 28, 2020, which brought Ted W Love around $3 Million.
According to the SEC Form 4 filings, Ted W Love has made a total of 0 transactions in Cascadian Therapeutics Inc (CASC) over the past 5 years. The most-recent trade in Cascadian Therapeutics Inc is the acquisition of 23,000 shares on February 2, 2017, which cost Ted W Love around $97,520.
Insider Trading History of Ted W Love
- 1
Ted W Love Trading Performance
GuruFocus tracks the stock performance after each of Ted W Love's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ted W Love is -7.93%. GuruFocus also compares Ted W Love's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ted W Love within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ted W Love's insider trading performs compared to the benchmark.
Performance of Ted W Love
Average Return
33.58%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.39 | -7.93 | -37.72 | 33.58 | -28.14 | -2.68 |
| Relative Return to S&P 500(%) | -1.94 | -9.12 | -37.86 | 21.14 | -35.64 | -13.34 |
Ted W Love Ownership Network
Ownership Network List of Ted W Love
Ownership Network Relation of Ted W Love
Ted W Love Owned Company Details
What does Seagen Inc do?
Who are the key executives at Seagen Inc?
Ted W Love is the director of Seagen Inc. Other key executives at Seagen Inc include director & Chief Executive Officer David R Epstein , See Remarks Vaughn B Himes , and EVP & Commercial Charles R Romp .
Seagen Inc (SGEN) Insider Trades Summary
Over the past 18 months, Ted W Love made no insider transaction in Seagen Inc (SGEN). Other recent insider transactions involving Seagen Inc (SGEN) include a net sale of 36,447 shares made by Jean I Liu , a net sale of 46,232 shares made by Roger D Dansey , and a net sale of 161,013 shares made by Todd E Simpson .
In summary, during the past 3 months, insiders sold 0 shares of Seagen Inc (SGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 413,479 shares of Seagen Inc (SGEN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 413,479 shares.
Seagen Inc (SGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Seagen Inc Insider Transactions
Ted W Love Mailing Address
Above is the net worth, insider trading, and ownership report for Ted W Love. You might contact Ted W Love via mailing address: C/o Global Blood Therapeutics, Inc., 400 East Jamie Court, Suite 101, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
